Get a front row seat to learn of the key developments impacting the pharmaceutical development and manufacturing value chain. This must-attend event consists of short presentation of no more than 10 minutes, including Q&A, by senior executives of DCAT Registered Member Companies highlighting recent major decisions (occurring from January 2017 through March 2017) that cover the following:
Presenting companies for 2017 included: Noramco, Datwyler, Mayne Pharma, Novasep, Catalent, CMC Biologics, Olon S.p.A., CordenPharma, Patheon, Siegfried, BioVectra and Lubrizol/Particle Sciences. View the schedule of speakers here.
This is a complimentary program for DCAT member company representatives.
Accredited members of the industry/trade press interested in attending should contact Erin Sanders at email@example.com.
For information on the 2018 podium time criteria and application process, click here.
The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing.